Assari Shervin, Burgard Sarah
Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA ; Center for Research on Ethnicity, Culture and Health, School of Public Health, Ann Arbor, University of Michigan, USA.
Department of Sociology, University of Michigan, Ann Arbor, Michigan, USA ; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
J Renal Inj Prev. 2015 Dec 5;4(4):127-34. doi: 10.12861/jrip.2015.27. eCollection 2015.
More studies are needed to examine whether race moderates the effect of baseline depressive symptoms on cause-specific mortality including deaths due to renal diseases in the United States.
The present longitudinal study compared Blacks and Whites for the effect of baseline depressive symptoms on deaths due to renal diseases over a 25-year period in a nationally representative community sample.
Data came from the Americans' Changing Lives (ACL) study, a nationally representative cohort that followed 3361 Black (n = 1156) or White (n = 2205) adults 25 and older for up to 25 years from 1986 to 2011. Month, year and cause of death were extracted from death certificates or national death index reports and coded based on ICD-9 or ICD-10 codes, depending on the year of death. We used Cox proportional hazards models for data analysis. Time to death due to renal diseases over a 25-year period was the outcome, baseline depressive symptoms (11-item Center for Epidemiological Studies-Depression [CES-D]) was the predictor, demographic characteristics, socio-economic status and chronic medical conditions (CMC) (hypertension, diabetes, chronic lung disease, heart disease, stroke, cancer, and arthritis) at baseline were controls, and race was the focal moderator.
In the pooled sample, race and baseline depressive symptoms showed a significant interaction, suggesting a stronger effect of baseline depressive symptoms on deaths due to renal diseases for Whites compared to Blacks. In race-specific models, high depressive symptoms at baseline increased risk of death due to renal diseases among Whites but not Blacks.
The Black-White difference in the predictive role of baseline depressive symptoms on deaths due to renal diseases over a 25-year period found here provides support for the Black-White health paradox.
需要更多研究来检验种族是否会调节基线抑郁症状对特定病因死亡率的影响,包括美国因肾脏疾病导致的死亡。
本纵向研究在一个具有全国代表性的社区样本中,比较了黑人和白人在25年期间基线抑郁症状对因肾脏疾病导致死亡的影响。
数据来自“美国人生活变化”(ACL)研究,这是一个具有全国代表性的队列,从1986年到2011年对3361名25岁及以上的黑人(n = 1156)或白人(n = 2205)成年人进行了长达25年的跟踪。死亡月份、年份和死因从死亡证明或国家死亡指数报告中提取,并根据死亡年份依据国际疾病分类第9版(ICD - 9)或第10版(ICD - 10)编码。我们使用Cox比例风险模型进行数据分析。25年期间因肾脏疾病导致死亡的时间为结局变量,基线抑郁症状(11项流行病学研究中心抑郁量表[CES - D])为预测变量,基线时的人口统计学特征、社会经济地位和慢性疾病(高血压、糖尿病、慢性肺病、心脏病、中风、癌症和关节炎)为控制变量,种族为重点调节变量。
在合并样本中,种族和基线抑郁症状显示出显著的交互作用,表明与黑人相比,基线抑郁症状对白人因肾脏疾病导致死亡的影响更强。在按种族划分的模型中,基线时高抑郁症状增加了白人因肾脏疾病导致死亡的风险,但对黑人没有影响。
此处发现的25年期间基线抑郁症状对因肾脏疾病导致死亡的预测作用的黑白差异,为黑白健康悖论提供了支持。